TNF and spondyloarthropathy: Lower rates of seroconversion to the hepatitis B vaccine have been reported during TNF inhibitor therapy in patients with spondyloarthropathies [68] or IBD [79,80], although another study found no difference in seroconversion rates between IBD patients receiving TNF inhibitors, or immunomodulators, or their combination [81].